NCT03115060

Brief Summary

Fluid management being an important component of surgery becomes more challenging for an anesthesiologist in case of renal transplant. Ischemia-reperfusion injury is an inevitable consequence of kidney transplantation, leading to metabolic acidosis .Normal saline (NS; 0.9% NaCl) is administered during kidney transplantation to avoid the risk of hyperkalemia associated with potassium-containing fluids. Plasmalyte is another fluid which can be used and probably will lead to better metabolic profile in these group of patients.The primary objective of this study will be to compare the effects of using normal saline (NS), Ringer lactate and Plasmalyte as intravenous fluids on acid-base balance and electrolytes during living donor kidney transplantation. Secondary outcomes assessed will be the effect on renal function.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
105

participants targeted

Target at P50-P75 for phase_4

Timeline
Completed

Started Apr 2015

Typical duration for phase_4

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2015

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

April 6, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 14, 2017

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2018

Completed
Last Updated

May 15, 2017

Status Verified

April 1, 2017

Enrollment Period

3 years

First QC Date

April 6, 2017

Last Update Submit

May 12, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • acid base balance, 4 readings intraoperaively to be taken using arterial blood sample of the patient

    pH, pCO2, pO2, HCO3,Base deficit, Na, K are the values normally measured in acid base analysis

    during the surgery

Secondary Outcomes (2)

  • serum creatinine on day 1, 2 and 7 of surgery

    day 1, 2 and 7

  • intraoperative hemodynamics in all patients

    intraoperatively

Study Arms (3)

normal saline

EXPERIMENTAL

Intravenous fluid used in these patients would be normal saline which would be given intravenously during intraoperative and postoperative period

Drug: intravenous fluid administration WITH NORMAL SALINE, PLASMALYTE A, OR RINGER LACTATE

ringer lactate

EXPERIMENTAL

Intravenous fluid used in these patients would be ringer lactate which would be given intravenously during intraoperative and postoperative period

Drug: intravenous fluid administration WITH NORMAL SALINE, PLASMALYTE A, OR RINGER LACTATE

plasmalyte A

EXPERIMENTAL

Intravenous fluid used in this arm in patients would be plasmalyte A which would be given intravenously during intraoperative and postoperative period

Drug: intravenous fluid administration WITH NORMAL SALINE, PLASMALYTE A, OR RINGER LACTATE

Interventions

intravenous fluid to be used for maintainance and replacement during renal transplant surgery will be normal saline, ringer lactate or plasmalyte A depending on the arm of intervention

normal salineplasmalyte Aringer lactate

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • patients undergoing elective living donor renal transplant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

PGIMER

Chandigarh, 160012, India

RECRUITING

MeSH Terms

Interventions

Saline SolutionPlasmalyte A

Intervention Hierarchy (Ancestors)

Crystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Central Study Contacts

Tanvir samra, MD Anaesthesia

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 6, 2017

First Posted

April 14, 2017

Study Start

April 1, 2015

Primary Completion

April 1, 2018

Study Completion

April 1, 2018

Last Updated

May 15, 2017

Record last verified: 2017-04

Data Sharing

IPD Sharing
Will not share

Locations